Advisor Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Advisor Group’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,290	Closed	-$65K	–	5397
2018 Q3	$65K	Buy	19,290 +6,000	+45%	+$21.6K	﹤0.01%	3090
2018 Q2	$50K	Sell	13,290 -2,600	-16%	-$12.7K	﹤0.01%	3118
2018 Q1	$65K	Sell	15,890 -1,550	-9%	-$7.22K	﹤0.01%	2879
2017 Q4	$80K	Buy	17,440 +9,095	+109%	+$50.1K	﹤0.01%	2748
2017 Q3	$60K	Sell	8,345 -1,220	-13%	-$8.77K	﹤0.01%	2813
2017 Q2	$69K	Sell	9,565 -38,320	-80%	-$239K	﹤0.01%	2601
2017 Q1	$295K	Sell	47,885 -4,505	-9%	-$24.7K	0.01%	1397
2016 Q4	$308K	Buy	52,390 +14,335	+38%	+$78.3K	0.01%	1287
2016 Q3	$203K	Buy	38,055 +5,225	+16%	+$28.2K	﹤0.01%	1514
2016 Q2	$216K	Buy	+32,830	New	+$184K	0.01%	1417

Advisor Group's KERX Position: Q4 2018 in Review

Advisor Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 19,290 shares — an estimated $65K sold.

Advisor Group first reported a position in KERX in Q2 2016 and held it in 10 quarters. The position peaked at $308K in Q4 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Advisor Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Advisor Group sold 19,290 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $65K.
Advisor Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2016 and held it in 10 quarters.
Advisor Group's Keryx Biopharmaceuticals Inc position peaked at $308K in Q4 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.